Utility of baseline serum phosphorus levels for predicting remission in acromegaly patients

[1] Melmed SS(2006)Medical progress: acromegaly N Engl J Med 355 2558-2573

[2] Chanson P(2008)Acromegaly Orphanet J Rare Dis 3 17-11

[3] Salenave S(1985)Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy J Clin Endocrinol Metab 61 7-25467

[4] Takamoto S(1995)Insulin-like growth factor I, a unique calcium-dependent stimulator of 1.25-dihydroxyvitamin D3 production. Studies in cultured mouse kidney cells J Biol Chem 270 25461-1235

[5] Tsuchiya H(1962)Some effects of human growth hormone on renal hemodynamics and on tubular phosphate transport in man J Clin Invest 41 1230-374

[6] Onishi T(1991)Effects of growth hormone and insulin like growth factor I on rabbit proximal convoluted tubule transport J Clin Invest 88 368-95

[7] Menaa C(2013)Clinicopathological features of growth hormone-producing pituitary adenomas in 242 acromegaly patients: classification according to hormone production and cytokeratin distribution, ISRN Endocrinol 2013 723432-3995

[8] Vrtovsnik F(2009)Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities Acta Diabetol 46 85-168

[9] Friedlander G(2014)Regulation of serum phosphate J Physiol 592 3985-450

[10] Corvilain J(2014)Therapy of acromegalic patients exacerbated by concomitant type 2 diabetes requires higher pegvisomant doses to normalise IGF1 levels Eur J Endocrinol 17 159-1005

[1] Melmed SS(2006)Medical progress: acromegaly N Engl J Med 355 2558-2573

[2] Chanson P(2008)Acromegaly Orphanet J Rare Dis 3 17-11

[3] Salenave S(1985)Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy J Clin Endocrinol Metab 61 7-25467

[4] Takamoto S(1995)Insulin-like growth factor I, a unique calcium-dependent stimulator of 1.25-dihydroxyvitamin D3 production. Studies in cultured mouse kidney cells J Biol Chem 270 25461-1235

[5] Tsuchiya H(1962)Some effects of human growth hormone on renal hemodynamics and on tubular phosphate transport in man J Clin Invest 41 1230-374

[6] Onishi T(1991)Effects of growth hormone and insulin like growth factor I on rabbit proximal convoluted tubule transport J Clin Invest 88 368-95

[7] Menaa C(2013)Clinicopathological features of growth hormone-producing pituitary adenomas in 242 acromegaly patients: classification according to hormone production and cytokeratin distribution, ISRN Endocrinol 2013 723432-3995

[8] Vrtovsnik F(2009)Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities Acta Diabetol 46 85-168

[9] Friedlander G(2014)Regulation of serum phosphate J Physiol 592 3985-450

[10] Corvilain J(2014)Therapy of acromegalic patients exacerbated by concomitant type 2 diabetes requires higher pegvisomant doses to normalise IGF1 levels Eur J Endocrinol 17 159-1005